The inaugural Longevity Therapeutics Summit, a conference devoted to transforming the latest developments in aging research into therapies targeting age-related diseases, will be held January 29–31, 2019, in San Francisco.
Registration is now open. Early bird registration (savings of 10–15%) ends November 16. Hourglass is a media partner for the event, and we’re pleased to announce that our readers can save an additional 10% on registration using discount code HRGLS10.
Together, the speakers promise to deliver an exciting program that will crystallize this moment in the field of aging. More so than is usually the case for a conference of this size, there will be something for everyone: scientists, entrepreneurs, and innovators from other fields who are beginning to understand the potential of anti-aging medicine.
Readers of Hourglass already understand the importance of gatherings like this, but I’ll close with a few words from the conference organizers:
With rapid advances in the understanding of the underlying biology and mechanisms of aging, ground-breaking research and technology have now started to come together to target the aging process and mitigate the effects of age-related diseases.
The inaugural Longevity Therapeutics 2019 will bring together the leading biotech drug developers, academics, investors and pharma companies endeavoring to develop innovative therapies targeting age-related conditions.
Join them to collaboratively tackle specific challenges faced to develop these therapies – from discovery, to preclinical activities, translational research, clinical development, regulatory and commercial considerations – and uncover the details behind the latest developments in this space.
Hourglass will be there to cover the summit. We hope to see you there!